Work

Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti–Programmed Death 1 Immunotherapy for Recurrent Liver Tumors

Year: 2020

Type: article

Source: Liver Transplantation

DOI: 10.1002/lt.25887

Authors: Guo‐Ming Shi, Jiping Wang, Xiao‐Wu Huang, Xiao‐Yong Huang, Yi‐Feng He, Yuan Ji, Yi Chen, Dong Wu, Jia‐Cheng Lu, Qi‐Man Sun, Wei‐Ren Liu, Ting Wang, Liu‐Xiao Yang, Ying‐Yong Hou, Ying‐Hong Shi, Jian Sun, Yong‐Sheng Xiao, Zheng Wang, Jia Fan, Monica M. Bertagnolli, Jian Zhou

Institutions: Ministry of Education of the People's Republic of China, Fudan University, Zhongshan Hospital, Brigham and Women's Hospital, Harvard University, Fudan University Shanghai Cancer Center, State Key Laboratory of Genetic Engineering

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3084130767

FWCI: 2.167

Cites: 5

Cited by: 53

Related to: 10